Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tito Fojo

Showing results (51-60 of 237) with videos related to

Pageof 24
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 5, 2025
Opportunities for Harmonization of US Food and Drug Administration Regulatory Decisions Exemplified by the Traditional Approval of Sotorasib and Panitumumab for Colorectal CancerMark J Ratain, Antonio Tito Fojo
JAMA Otolaryngology-- Head & Neck Surgery|July 29, 2014
Unintended consequences of expensive cancer therapeutics—the pursuit of marginal indications and a me-too mentality that stifles innovation and creativity: the John Conley LectureTito Fojo, Sham Mailankody, Andrew Lo
JAMA Oncology|March 9, 2023
Requirements for Meaningful Progress in the Therapy of Neuroendocrine CancersBrian W Labadie, Antonio Tito Fojo
JAMA Oncology|June 10, 2016
An Appraisal of Clinically Meaningful Outcomes Guidelines for Oncology Clinical TrialsHemanth Kumar, Tito Fojo, Sham Mailankody
The Oncologist|August 12, 2025
Harvesting information from Kaplan-Meier plots: part 2-detecting informative censoring as the starting point for an in-depth analysis. Sotorasib plus panitumumab in colorectal cancer as an exampleBrandon DaSilva, Mengxi Zhou, Tito Fojo
Seminars in Oncology|August 11, 2020
Distribution of cancer genes in human chromosomesBahar Laderian, Mengxi Zhou, Tito Fojo
The Lancet. Oncology|April 8, 2015
Non-inferiority trials: why oncologists must remain waryMauricio Burotto, Vinay Prasad, Tito Fojo
The Lancet. Oncology|February 13, 2016
Precision oncology: origins, optimism, and potentialVinay Prasad, Tito Fojo, Michael Brada
Nature Reviews. Clinical Oncology|July 15, 2015
Pancreatic cancer: Targeting KRAS and the vitamin D receptor via microtubulesAgnes Basseville, Susan Bates, Tito Fojo
Nature Reviews. Cancer|April 2, 2005
Tumour stem cells and drug resistanceMichael Dean, Tito Fojo, Susan Bates
Pageof 24

Showing results (51-60 of 237) with videos related to

Sort By:
Pageof 24
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 5, 2025
Opportunities for Harmonization of US Food and Drug Administration Regulatory Decisions Exemplified by the Traditional Approval of Sotorasib and Panitumumab for Colorectal CancerMark J Ratain, Antonio Tito Fojo
JAMA Otolaryngology-- Head & Neck Surgery|July 29, 2014
Unintended consequences of expensive cancer therapeutics—the pursuit of marginal indications and a me-too mentality that stifles innovation and creativity: the John Conley LectureTito Fojo, Sham Mailankody, Andrew Lo
JAMA Oncology|March 9, 2023
Requirements for Meaningful Progress in the Therapy of Neuroendocrine CancersBrian W Labadie, Antonio Tito Fojo
JAMA Oncology|June 10, 2016
An Appraisal of Clinically Meaningful Outcomes Guidelines for Oncology Clinical TrialsHemanth Kumar, Tito Fojo, Sham Mailankody
The Oncologist|August 12, 2025
Harvesting information from Kaplan-Meier plots: part 2-detecting informative censoring as the starting point for an in-depth analysis. Sotorasib plus panitumumab in colorectal cancer as an exampleBrandon DaSilva, Mengxi Zhou, Tito Fojo
Seminars in Oncology|August 11, 2020
Distribution of cancer genes in human chromosomesBahar Laderian, Mengxi Zhou, Tito Fojo
The Lancet. Oncology|April 8, 2015
Non-inferiority trials: why oncologists must remain waryMauricio Burotto, Vinay Prasad, Tito Fojo
The Lancet. Oncology|February 13, 2016
Precision oncology: origins, optimism, and potentialVinay Prasad, Tito Fojo, Michael Brada
Nature Reviews. Clinical Oncology|July 15, 2015
Pancreatic cancer: Targeting KRAS and the vitamin D receptor via microtubulesAgnes Basseville, Susan Bates, Tito Fojo
Nature Reviews. Cancer|April 2, 2005
Tumour stem cells and drug resistanceMichael Dean, Tito Fojo, Susan Bates
Pageof 24